Viewing StudyNCT00305617



Ignite Creation Date: 2024-05-05 @ 4:44 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00305617
Status: COMPLETED
Last Update Posted: 2011-05-17
First Post: 2006-03-21

Brief Title: Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer
Sponsor: The Cleveland Clinic
Organization: The Cleveland Clinic

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Keywords:
Name View
stage IIIB non-small cell lung cancer View
stage IIIA non-small cell lung cancer View